PURPOSE: Here, the authors explore the feasibility of discriminating cancer patients from healthy controls by serum RNA detection based on surface-enhanced Raman spectroscopy (SERS) and multivariate analysis. METHODS: MgSO(4)-aggregated silver nanoparticles (Ag NP) as the SERS-active substrate presented strong SERS signals to RNA. SERS measurements were performed on two groups of serum RNA samples: one group from patients (n = 31) with gastric cancer and the other group from healthy volunteers (n = 34). RESULTS: Tentative assignments of the Raman bands in the normalized SERS spectra demonstrated that there are differential expressions of circulating RNA between the gastric cancer group and the control group. Principal component analysis (PCA) combined with linear discriminate analysis (LDA) was introduced to differentiate gastric cancer from normal and achieved sensitivity of 100% and specificity of 94.1%. CONCLUSIONS: This exploratory study demonstrated potential for developing serum RNA SERS analysis into a useful clinical tool for noninvasive screening and detection of cancer.
PURPOSE: Here, the authors explore the feasibility of discriminating cancerpatients from healthy controls by serum RNA detection based on surface-enhanced Raman spectroscopy (SERS) and multivariate analysis. METHODS:MgSO(4)-aggregated silver nanoparticles (Ag NP) as the SERS-active substrate presented strong SERS signals to RNA. SERS measurements were performed on two groups of serum RNA samples: one group from patients (n = 31) with gastric cancer and the other group from healthy volunteers (n = 34). RESULTS: Tentative assignments of the Raman bands in the normalized SERS spectra demonstrated that there are differential expressions of circulating RNA between the gastric cancer group and the control group. Principal component analysis (PCA) combined with linear discriminate analysis (LDA) was introduced to differentiate gastric cancer from normal and achieved sensitivity of 100% and specificity of 94.1%. CONCLUSIONS: This exploratory study demonstrated potential for developing serum RNA SERS analysis into a useful clinical tool for noninvasive screening and detection of cancer.
Authors: Kyung Sook Lee; Dong Kwan Oh; Mi Ah Han; Hoo-Yeon Lee; Jae Kwan Jun; Kui Son Choi; Eun-Cheol Park Journal: Cancer Res Treat Date: 2011-06-30 Impact factor: 4.679
Authors: J D Driskell; A G Seto; L P Jones; S Jokela; R A Dluhy; Y-P Zhao; R A Tripp Journal: Biosens Bioelectron Date: 2008-08-06 Impact factor: 10.618
Authors: Jeremy D Driskell; Oliva M Primera-Pedrozo; Richard A Dluhy; Yiping Zhao; Ralph A Tripp Journal: Appl Spectrosc Date: 2009-10 Impact factor: 2.388
Authors: Na Li; Bin Tang; En-Dong Zhu; Bo-sheng Li; Yuan Zhuang; Shu Yu; Dong-shui Lu; Quan-Ming Zou; Bin Xiao; Xu-Hu Mao Journal: FEBS Lett Date: 2012-02-02 Impact factor: 4.124
Authors: Willie C Zúñiga; Veronica Jones; Sarah M Anderson; Alex Echevarria; Nathaniel L Miller; Connor Stashko; Daniel Schmolze; Philip D Cha; Ragini Kothari; Yuman Fong; Michael C Storrie-Lombardi Journal: Sci Rep Date: 2019-10-10 Impact factor: 4.379
Authors: Lucretia Avram; Stefania D Iancu; Andrei Stefancu; Vlad Moisoiu; Alia Colnita; Daniel Marconi; Valer Donca; Elena Buzdugan; Rares Craciun; Nicolae Leopold; Nicolae Crisan; Ioan Coman; Dana Crisan Journal: J Clin Med Date: 2020-01-13 Impact factor: 4.241